Similarly, other risk factors could have been used to define a high-risk patient group [31], such as relatively low baseline levels of Ki-67 and tumor-infiltrating lymphocytes, a young age at diagnosis, and a higher body mass index [7], but this approach would yield more complicated and therefore potentially less replicable criteria restricted by data availability. Here, MKI67 is linked to neoplasm.